Miller, A. Austin
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Miller, Arthur Austin 1900-1968
Miller, A. Austin (Arthur Austin), 1900-
Austin Miller researcher
Miller, Arthur Austin, 1900-
Miller, A. Austin (Arthur Austin)
Miller, Austin
VIAF ID: 119193109 (Personal)
Permalink: http://viaf.org/viaf/119193109
Preferred Forms
-
100 0 _
‡a
Austin Miller
‡c
researcher
-
100 1 _
‡a
Miller, A. Austin
-
100 1 _
‡a
Miller, A. Austin
-
100 1 _ ‡a Miller, A. Austin
-
100 1 _
‡a
Miller, A. Austin
‡q
(Arthur Austin)
-
100 1 _
‡a
Miller, A. Austin
‡q
(Arthur Austin),
‡d
1900-
-
100 1 _ ‡a Miller, A. Austin ‡q (Arthur Austin), ‡d 1900-
-
100 1 _ ‡a Miller, Arthur Austin ‡d (1900-1968).
-
100 1 _
‡a
Miller, Arthur Austin
‡d
1900-1968
-
100 1 _ ‡a Miller, Arthur Austin, ‡d 1900-
-
100 1 _ ‡a Miller, Austin
4xx's: Alternate Name Forms (11)
5xx's: Related Names (4)
- 551 _ _
‡a
London
‡4
orts
‡4
https://d-nb.info/standards/elementset/gnd#placeOfDeath
- 551 _ _
‡a
Reading
‡4
ortw
‡4
https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _
‡a
University of Reading
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
- 551 _ _
‡a
Wrangle
‡4
ortg
‡4
https://d-nb.info/standards/elementset/gnd#placeOfBirth
Works
| Title | Sources |
|---|---|
| Climatology |
|
| Daily Time of Radiation Treatment is Associated with Subsequent Oral Mucositis Severity during Radiotherapy in Head and Neck Cancer Patients |
|
| Development and Evaluation of an Accelerometer-Based Protocol for Measuring Physical Activity Levels in Cancer Survivors: Development and Usability Study |
|
| Essays in geography for Austin Miller. |
|
| Everyday meteorology |
|
| L' evolution du paysage dans les basses terres d'Angleterre |
|
| Expression of the POTE gene family in human ovarian cancer |
|
| The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
|
| Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
|
| The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production |
|
| Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study |
|
| Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
|
| Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations |
|
| Outcome of Everolimus-Based Therapy in Hormone-Receptor-Positive Metastatic Breast Cancer Patients After Progression on Palbociclib |
|
| Pralatrexate in Combination with Oxaliplatin in Advanced Esophagogastric Cancer: A Phase II Trial with Predictive Molecular Correlates |
|
| A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology/Gynecologic Oncology Group (GOG-225) S |
|
| Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199) |
|
| Shared heritability and functional enrichment across six solid cancers |
|
| A single-institution, randomized, pilot study evaluating the efficacy of gabapentin and methadone for patients undergoing chemoradiation for head and neck squamous cell cancer |
|
| The skin of the earth. |
|
| Specialized Proresolving Mediators Overcome Immune Suppression Induced by Exposure to Secondhand Smoke |
|
| TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer |
|
| Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
|
